from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3684/-

LFCtreatmentdescriptionclass of inhibitor

-1.120

Amikacinug/mL Amikacintranslation

-2.099

Cap5-10ug/mL Capreomycintranslation

-2.668

Rox10-50 ug/mL Roxithromycintranslation

0.045

SM2-5 ug/mL Streptomycintranslation

-1.803

Tet5-10 ug/mL Tetracyclinetranslation

1.163

Rif0.2-5ug/mL Rifampicintranscription

0.115

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.215

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.002

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.644

CPZ10-50 ug/mL Chlorpromazinerespiration

0.524

Clofazimine10-13 ug/mL Clofaziminerespiration

0.057

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.116

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.638

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.702

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.135

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.108

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.836

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.429

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.466

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.750

KCN5-20 ug/mL Potassium cyaniderespiration

0.641

NaN30.2-2 mM Sodium aziderespiration

0.251

Nigericin50 uM Nigericinrespiration

-0.007

TRC10-150 ug/mL Triclosanrespiration

-1.038

TRZ10-25 ug/mL Thioridazinerespiration

-3.208

Valinomycin0.5-10 uM Valinomycinrespiration

-0.061

ZnSO42 mM ZnSO4respiration

0.135

menadione6-10 ug/mL Menadionerespiration

1.231

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.476

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.450

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.896

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.240

NRP_1Non-replicating persistence stage 1dosRassociated

0.218

Amp0.2mg/mL AmpicillincellWall

0.230

Cephalexin20-100 ug/mL CephalexincellWall

0.601

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.187

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.368

EMB10-20 ug/mL EthambutolcellWall

0.341

Eta12-40 ug/mL EthionamidecellWall

0.188

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.079

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.294

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.118

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.874

BZA0.12 mg/mL BenzamidearomaticAmides

-0.286

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.682

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.232

H2O24 mM hydrogen peroxideDNAdamaging

0.348

Levo10 ug/mL LevofloxacinDNAdamaging

0.389

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.201

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.292

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.013

UVUV-irradiationDNAdamaging

-0.672

ARP41-4 ug/mL Antitubercular compound ARP4?

0.531

Antimycin12.5-50 ug/mL Antimycin A?

0.593

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.364

PA_110-50 ug/mL Antitubercular compound PA-1?

0.271

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.315

PA8240.2-2 ug/mL PA-824?

0.071

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.410

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.871

Verapamil50 uM Verapamil?

0.629

mercaptoethanol2 mM 2-Mercaptoethanol?

0.921

methoxatin10-20 ug/mL Methoxatin?